Evidence that intracoronary-injected CD133+ peripheral blood progenitor cells home to the myocardium in chronic postinfarction heart failure.

@article{Schots2007EvidenceTI,
  title={Evidence that intracoronary-injected CD133+ peripheral blood progenitor cells home to the myocardium in chronic postinfarction heart failure.},
  author={Rik Schots and Gilles W. De Keulenaer and Danny Schoors and Vicky Caveliers and Martine I. Dujardin and Stefan Verheye and Guy Van Camp and Philippe R. Franken and Jan Roland and Ivan van Riet and Hendrik Everaert},
  journal={Experimental hematology},
  year={2007},
  volume={35 12},
  pages={1884-90}
}
OBJECTIVE To study the biodistribution of purified CD133(+) cells after intracoronary injection in patients with stable chronic postinfarction heart failure. PATIENTS AND METHODS Patients with longstanding myocardial infarction (>12 months prior to inclusion) and with an accessible left coronary artery were eligible. CD133(+) cells were mobilized with granulocyte colony-stimulating factor and purified with a CliniMACS device. Cells were labeled with (111)Indium and injected through a balloon… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 17 extracted citations

The effect of anti-CD133/fucoidan bio-coatings on hemocompatibility and EPC capture.

Journal of biomaterials science. Polymer edition • 2017
View 1 Excerpt

Similar Papers

Loading similar papers…